Sales & Marketing Views & Analysis

Views & Analysis

Nine for 2021: Addressing the pandemic legacy

In this second 'Nine for 2021' article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact pharma in 2021: t

Views & Analysis

Are face-to-face medical meetings a thing of the past?

Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.

Views & Analysis

COVID-19 and the digital pharma marketing revolution

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules.

Views & Analysis

2021 Outlook: The future for life sciences customer experien...

Research from a large-scale survey of 1000+ senior pharma professionals has highlighted the divide between digitally adept companies and those that have been slow to adopt technologies.

Views & Analysis

The top 5 pharma M&A deals of 2020

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers –

Views & Analysis

ABPI chief exec on the UK industry’s learnings from COVID-19

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 and explains why the post-pandemic future is looking bright for the UK industry.

Nine for 2021: Addressing the pandemic legacy

Are face-to-face medical meetings a thing of the past?

COVID-19 and the digital pharma marketing revolution

2021 Outlook: The future for life sciences customer experien...

The top 5 pharma M&A deals of 2020

ABPI chief exec on the UK industry’s learnings from COVID-19

AI specialist Chai Discovery raises $400m

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks